|
1
|
Muggia FM and Green MD: New anthracycline
antitumor antibiotics. Crit Rev Oncol Hematol. 11:43–64. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Weiss RB: The anthracyclines: Will we ever
find a better doxorubicin? Semin Oncol. 19:670–686. 1992.PubMed/NCBI
|
|
3
|
Lipshultz SE, Colan SD, Gelber RD,
Perez-Atayde AR, Sallan SE and Sanders SP: Late cardiac effects of
doxorubicin therapy for acute lymphoblastic leukemia in childhood.
New Engl J Med. 324:808–815. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shan K, Lincoff AM and Young JB:
Anthracycline-induced cardiotoxicity. Ann Intern Med. 125:47–58.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Doroshow JH: Effect of anthracycline
antibiotics on oxygen radical formation in rat heart. Cancer Res.
43:460–472. 1983.PubMed/NCBI
|
|
6
|
Olson RD and Mushlin PS: Doxorubicin
cardiotoxicity: Analysis of prevailing hypotheses. FASEB J.
4:3076–3086. 1990.PubMed/NCBI
|
|
7
|
Danz ED, Skramsted J, Henry N, Bennett JA
and Keller RS: Resveratrol prevents doxorubicin cardiotoxicity
through mitochondrial stabilization and the Sirt1 pathway. Free
Radic Biol Med. 46:1589–1597. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dirks-Naylor AJ: The role of autophagy in
doxorubicin-induced cardiotoxicity. Life Sci. 93:913–916. 2013.
View Article : Google Scholar
|
|
9
|
Rasheva VI and Domingos PM: Cellular
responses to endoplasmic reticulum stress and apoptosis. Apoptosis.
14:996–1007. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Oyadomari S and Mori M: Roles of
CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ.
11:381–389. 2004. View Article : Google Scholar
|
|
11
|
Zinszner H, Kuroda M, Wang X, Batchvarova
N, Lightfoot RT, Remotti H, Stevens JL and Ron D: CHOP is
implicated in programmed cell death in response to impaired
function of the endoplasmic reticulum. Genes Dev. 12:982–995. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ron D and Walter P: Signal integration in
the endoplasmic reticulum unfolded protein response. Nat Rev Mol
Cell Biol. 8:519–529. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Schröder M: The unfolded protein response.
Mol Biotechnol. 34:279–290. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zu K, Bihani T, Lin A, Park YM, Mori K and
Ip C: Enhanced selenium effect on growth arrest by Bip/GRP78
knockdown in p53-null human prostate cancer cells. Oncogene.
25:546–554. 2006.
|
|
15
|
Xu C, Bailly-Maitre B and Reed JC:
Endoplasmic reticulum stress: cell life and death decisions. J Clin
Invest. 115:2656–2664. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu J, Mao W, Iwai C, Fukuoka S, Vulapalli
R, Huang H, Wang T, Sharma VK, Sheu SS, Fu M and Liang CS: Adoptive
passive transfer of rabbit beta1-adrenoceptor peptide immune
cardiomyopathy into the Rag2-/- mouse: Participation of the ER
stress. J Mol Cell Cardiol. 44:304–314. 2008. View Article : Google Scholar
|
|
17
|
Mandl J and Bánhegyi G: Endoplasmic
reticulum stress - common pathomechanism of different diseases? Orv
Hetil. 148:1779–1785. 2007.In Hungarian. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chua CC, Liu X, Gao J, Hamdy RC and Chua
BH: Multiple actions of pifithrin-alpha on doxorubicin-induced
apoptosis in rat myoblastic H9c2 cells. Am J Physiol Heart Circ
Phys. 290:H2606–H2613. 2006. View Article : Google Scholar
|
|
19
|
Lai HC, Yeh YC, Ting CT, Lee WL, Lee HW,
Wang LC, Wang KY, Lai HC, Wu A and Liu TJ: Doxycycline suppresses
doxorubicin-induced oxidative stress and cellular apoptosis in
mouse hearts. Eur J Pharmacol. 644:176–187. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Reeve JL, Szegezdi E, Logue SE, Ní
Chonghaile T, O'Brien T, Ritter T and Samali A: Distinct mechanisms
of cardiomyocyte apoptosis induced by doxorubicin and hypoxia
converge on mitochondria and are inhibited by Bcl-xL. J Cell Mol
Med. 11:509–520. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lu M, Merali S, Gordon R, Jiang J, Li Y,
Mandeli J, Duan X, Fallon J and Holland JF: Prevention of
Doxorubicin cardiopathic changes by a benzyl styryl sulfone in
mice. Genes Cancer. 2:985–992. 2011. View Article : Google Scholar
|
|
22
|
Das DK, Sato M, Ray PS, Maulik G, Engelman
RM, Bertelli AA and Bertelli A: Cardioprotection of red wine: Role
of polyphenolic antioxidants. Drugs Exp Clin Res. 25:115–120.
1999.PubMed/NCBI
|
|
23
|
Orallo F, Alvarez E, Camiña M, Leiro JM,
Gómez E and Fernández P: The possible implication of
trans-Resveratrol in the cardioprotective effects of long-term
moderate wine consumption. Mol Pharmacol. 61:294–302. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sabe AA, Sadek AA, Elmadhun NY, Dalal RS,
Robich MP, Bianchi C and Sellke FW: Investigating the effects of
resveratrol on chronically ischemic myocardium in a Swine model of
metabolic syndrome: A proteomics analysis. J Med Food. 18:60–66.
2015. View Article : Google Scholar
|
|
25
|
Gu XS, Wang ZB, Ye Z, Lei JP, Li L, Su DF
and Zheng X: Resveratrol, an activator of SIRT1, upregulates AMPK
and improves cardiac function in heart failure. Genet Mol Res.
13:323–335. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dolinsky VW, Rogan KJ, Sung MM, Zordoky
BN, Haykowsky MJ, Young ME, Jones LW and Dyck JR: Both aerobic
exercise and resveratrol supplementation attenuate
doxorubicin-induced cardiac injury in mice. Am J Physiol Endocrinol
Metab. 305:E243–E253. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Brachmann CB, Sherman JM, Devine SE,
Cameron EE, Pillus L and Boeke JD: The SIR2 gene family, conserved
from bacteria to humans, functions in silencing, cell cycle
progression, and chromosome stability. Genes Dev. 9:2888–2902.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bitterman KJ, Anderson RM, Cohen HY,
Latorre-Esteves M and Sinclair DA: Inhibition of silencing and
accelerated aging by nicotinamide, a putative negative regulator of
yeast sir2 and human SIRT1. J Biol Chem. 277:45099–45107. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Blander G and Guarente L: The Sir2 family
of protein deacetylases. Ann Rev Biochem. 73:417–435. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Brunet A, Sweeney LB, Sturgill JF, Chua
KF, Greer PL, Lin Y, Tran H, Ross SE, Mostoslavsky R, Cohen HY, et
al: Stress-dependent regulation of FOXO transcription factors by
the SIRT1 deacetylase. Science. 303:2011–2015. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen CJ, Yu W, Fu YC, Wang X, Li JL and
Wang W: Resveratrol protects cardiomyocytes from hypoxia-induced
apoptosis through the SIRT1-FoxO1 pathway. Biochem Biophys Res
Commun. 378:389–393. 2009. View Article : Google Scholar
|
|
32
|
Hsu CP, Zhai P, Yamamoto T, Maejima Y,
Matsushima S, Hariharan N, Shao D, Takagi H, Oka S and Sadoshima J:
Silent information regulator 1 protects the heart from
ischemia/reperfusion. Circulation. 122:2170–2182. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Alcendor RR, Gao S, Zhai P, Zablocki D,
Holle E, Yu X, Tian B, Wagner T, Vatner SF and Sadoshima J: Sirt1
regulates aging and resistance to oxidative stress in the heart.
Circ Res. 100:1512–1521. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Howitz KT, Bitterman KJ, Cohen HY, Lamming
DW, Lavu S, Wood JG, Zipkin RE, Chung P, Kisielewski A, Zhang LL,
et al: Small molecule activators of sirtuins extend Saccharomyces
cerevisiae lifespan. Nature. 425:191–196. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lagouge M, Argmann C, Gerhart-Hines Z,
Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P,
Elliott P, et al: Resveratrol improves mitochondrial function and
protects against metabolic disease by activating SIRT1 and
PGC-1alpha. Cell. 127:1109–1122. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wood JG, Rogina B, Lavu S, Howitz K,
Helfand SL, Tatar M and Sinclair D: Sirtuin activators mimic
caloric restriction and delay ageing in metazoans. Nature.
430:686–689. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Liu LQ, Fan ZQ, Tang YF and Ke ZJ: The
resveratrol attenuates ethanol-induced hepatocyte apoptosis via
inhibiting ER-related caspase-12 activation and PDE activity in
vitro. Alcohol Clin Exp Res. 38:683–693. 2014. View Article : Google Scholar
|
|
38
|
Li YG, Zhu W, Tao JP, Xin P, Liu MY, Li JB
and Wei M: Resveratrol protects cardiomyocytes from oxidative
stress through SIRT1 and mitochondrial biogenesis signaling
pathways. Biochem Biophys Res Commun. 438:270–276. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chen B, Xue J, Meng X, Slutzky JL, Calvert
AE and Chicoine LG: Resveratrol prevents hypoxia-induced arginase
II expression and proliferation of human pulmonary artery smooth
muscle cells via Akt-dependent signaling. Am J Physiol Lung Cell
Mol Physiol. 307:L317–L325. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Arafa MH, Mohammad NS, Atteia HH and
Abd-Elaziz HR: Protective effect of resveratrol against
doxorubicin-induced cardiac toxicity and fibrosis in male
experimental rats. J Physiol Biochem. 70:701–711. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Huang JP, Huang SS, Deng JY, Chang CC, Day
YJ and Hung LM: Insulin and resveratrol act synergistically,
preventing cardiac dysfunction in diabetes, but the advantage of
resveratrol in diabetics with acute heart attack is antagonized by
insulin. Free Radic Biol Med. 49:1710–1721. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Yang DL, Zhang HG, Xu YL, Gao YH, Yang XJ,
Hao XQ and Li XH: Resveratrol inhibits right ventricular
hypertrophy induced by monocrotaline in rats. Clin Exp Pharmacol
Physiol. 37:150–155. 2010. View Article : Google Scholar
|
|
43
|
Chen YR, Yi FF, Li XY, Wang CY, Chen L,
Yang XC, Su PX and Cai J: Resveratrol attenuates ventricular
arrhythmias and improves the long-term survival in rats with
myocardial infarction. Cardiovasc Drugs Ther. 22:479–485. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wang XY, Yang CT, Zheng DD, Mo LQ, Lan AP,
Yang ZL, Hu F, Chen PX, Liao XX and Feng JQ: Hydrogen sulfide
protects H9c2 cells against doxorubicin-induced cardiotoxicity
through inhibition of endoplasmic reticulum stress. Mol Cell
Biochem. 363:419–426. 2012. View Article : Google Scholar
|
|
45
|
Zhang C, Feng Y, Qu S, Wei X, Zhu H, Luo
Q, Liu M, Chen G and Xiao X: Resveratrol attenuates
doxorubicin-induced cardiomyocyte apoptosis in mice through
SIRT1-mediated deacetylation of p53. Cardiovasc Res. 90:538–545.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Ueno M, Kakinuma Y, Yuhki K, Murakoshi N,
Iemitsu M, Miyauchi T and Yamaguchi I: Doxorubicin induces
apoptosis by activation of caspase-3 in cultured cardiomyocytes in
vitro and rat cardiac ventricles in vivo. J Pharmacol Sci.
101:151–158. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Sishi BJ, Loos B, van Rooyen J and
Engelbrecht AM: Doxorubicin induces protein ubiquitination and
inhibits proteasome activity during cardiotoxicity. Toxicology.
309:23–29. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Lv XC and Zhou HY: Resveratrol protects
H9c2 embryonic rat heart derived cells from oxidative stress by
inducing autophagy: Role of p38 mitogen-activated protein kinase.
Can J Physiol Pharmacol. 90:655–662. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Lekli I, Szabo G, Juhasz B, Das S, Das M,
Varga E, Szendrei L, Gesztelyi R, Varadi J, Bak I, et al:
Protective mechanisms of resveratrol against
ischemia-reperfusion-induced damage in hearts obtained from Zucker
obese rats: The role of GLUT-4 and endothelin. Am J Physiol Heart
Circ Physiol. 294:H859–H866. 2008. View Article : Google Scholar
|
|
50
|
Das S, Falchi M, Bertelli A, Maulik N and
Das DK: Attenuation of ischemia/reperfusion injury in rats by the
anti-inflammatory action of resveratrol. Arzneimittelforschung.
56:700–706. 2006.
|
|
51
|
Goh SS, Woodman OL, Pepe S, Cao AH, Qin C
and Ritchie RH: The red wine antioxidant resveratrol prevents
cardiomyocyte injury following ischemia-reperfusion via multiple
sites and mechanisms. Antioxid Redox Signal. 9:101–113. 2007.
View Article : Google Scholar
|
|
52
|
Hung LM, Su MJ, Chu WK, Chiao CW, Chan WF
and Chen JK: The protective effect of resveratrols on
ischaemia-reperfusion injuries of rat hearts is correlated with
antioxidant efficacy. Br J Pharmacol. 135:1627–1633. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
El-Mowafy AM and White RE: Resveratrol
inhibits MAPK activity and nuclear translocation in coronary artery
smooth muscle: Reversal of endothelin-1 stimulatory effects. FEBS
Lett. 451:63–67. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Yamamoto H, Schoonjans K and Auwerx J:
Sirtuin functions in health and disease. Mol Endocrinol.
21:1745–1755. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Becatti M, Taddei N, Cecchi C, Nassi N,
Nassi PA and Fiorillo C: SIRT1 modulates MAPK pathways in
ischemic-reperfused cardiomyocytes. Cell Mol Life Sci.
69:2245–2260. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Ungvari Z, Labinskyy N, Mukhopadhyay P,
Pinto JT, Bagi Z, Ballabh P, Zhang C, Pacher P and Csiszar A:
Resveratrol attenuates mitochondrial oxidative stress in coronary
arterial endothelial cells. Am J Physiol Heart Circ Physiol.
297:H1876–H1881. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Hsu CP, Odewale I, Alcendor RR and
Sadoshima J: Sirt1 protects the heart from aging and stress. Biol
Chem. 389:221–231. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Viswanathan M, Kim SK, Berdichevsky A and
Guarente L: A role for SIR-2.1 regulation of ER stress response
genes in determining C. elegans life span. Dev Cell. 9:605–615.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Li Y, Xu S, Giles A, Nakamura K, Lee JW,
Hou X, Donmez G, Li J, Luo Z, Walsh K, et al: Hepatic
overexpression of SIRT1 in mice attenuates endoplasmic reticulum
stress and insulin resistance in the liver. FASEB J. 25:1664–1679.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Jang M, Cai L, Udeani GO, Slowing KV,
Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta
RG, et al: Cancer chemopreventive activity of resveratrol, a
natural product derived from grapes. Science. 275:218–220. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Rezk YA, Balulad SS, Keller RS and Bennett
JA: Use of resveratrol to improve the effectiveness of cisplatin
and doxorubicin: Study in human gynecologic cancer cell lines and
in rodent heart. Am J Obstet Gynecol. 194:e23–e26. 2006. View Article : Google Scholar : PubMed/NCBI
|
